Insider · CIK 0001805812

Jacobson Mark L.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001805812

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$12.95	+$130K	10,000
2026-09-03	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−10K sh	$208.65	−$2.09M	0
2026-09-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	104,954
2026-05-05	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+233 sh	$12.95	+$3,017.35	233
2026-05-05	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−233 sh	$228.18	−$53.2K	0
2026-05-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−233 sh	—	—	114,954
2026-05-04	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+4,517 sh	$12.95	+$58.5K	4,517
2026-05-04	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,517 sh	$227.94	−$1.03M	0
2026-05-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−4,517 sh	—	—	115,187
2026-04-21	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+8,669 sh	—	—	8,669
2026-02-26	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+19.7K sh	—	—	19,663
2026-02-26	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+35.4K sh	$2.85	+$101K	35,378
2026-02-26	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−35.4K sh	$161.88	−$5.73M	0
2026-02-26	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−35.4K sh	—	—	0
2025-09-22	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+10K sh	$2.85	+$28.5K	10,000
2025-09-22	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−10K sh	$115.96	−$1.16M	0
2025-09-22	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−10K sh	—	—	35,378
2025-09-16	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,783 sh	$116.19	−$672K	0
2025-09-16	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$4.95	+$124K	25,000
2025-09-16	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+15K sh	$4.85	+$72.8K	40,000
2025-09-16	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−40K sh	$114.23	−$4.57M	0
2025-09-16	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2025-09-16	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15K sh	—	—	0
2025-06-09	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$8.02	+$201K	30,783
2025-06-09	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−25K sh	$110.44	−$2.76M	5,783
2025-06-09	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2025-05-28	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20K sh	$6.47	+$129K	25,783
2025-05-28	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−20K sh	$103.45	−$2.07M	5,783
2025-05-28	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20K sh	—	—	0
2025-05-27	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20.7K sh	$6.47	+$134K	26,456
2025-05-27	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−20.7K sh	$104.66	−$2.16M	5,783
2025-05-27	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20.7K sh	—	—	0
2025-02-24	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+10.8K sh	—	—	10,769
2025-02-21	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+10.9K sh	—	—	10,875
2025-02-21	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+10.8K sh	—	—	10,769
2024-08-09	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+47.7K sh	$4.04	+$193K	53,522
2024-08-09	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−47.7K sh	$84.26	−$4.02M	5,783
2024-08-09	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−47.7K sh	—	—	0
2024-05-29	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+13.7K sh	$1.30	+$17.8K	13,693
2024-05-29	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,910 sh	$74.31	−$588K	5,783
2024-05-29	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−13.7K sh	—	—	0
2024-04-01	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+24.7K sh	$1.30	+$32.1K	24,662
2024-04-01	AXSMAxsome Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−24.7K sh	$77.24	−$1.9M	0
2024-04-01	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−24.7K sh	—	—	0
2024-02-27	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+32.8K sh	—	—	32,825
2024-02-27	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+18K sh	—	—	18,027
2023-03-02	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+41.4K sh	—	—	41,424
2023-03-02	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+23.5K sh	—	—	23,491
2022-03-04	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+89.4K sh	—	—	89,405
2022-03-04	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+48K sh	—	—	47,990

Recent filings

Accepted (ET)
Sep 34
Jacobson Mark L.0001193125-26-382277
SEC(opens sec.gov)
May 54
Jacobson Mark L.0001193125-26-207148
SEC(opens sec.gov)
Apr 234
Jacobson Mark L.0001193125-26-174419
SEC(opens sec.gov)
Feb 274
Jacobson Mark L.0001193125-26-083586
SEC(opens sec.gov)
Feb 274
Jacobson Mark L.0001193125-26-083605
SEC(opens sec.gov)
Sep 224
Jacobson Mark L.0001193125-25-211788
SEC(opens sec.gov)
Sep 174
Jacobson Mark L.0001193125-25-206494
SEC(opens sec.gov)

Companies

Axsome Therapeutics, Inc.Chief Operating OfficerAXSM

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007